Jonathan Huberman - 04 Feb 2026 Form 4 Insider Report for CuriosityStream Inc. (CURI)

Reporting relationship: Director
Issuer ticker: CURI
Reported as of: 04 Feb 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Feb 2026, 12:19:41 UTC
Prior SEC filing: 24 Nov 2025
Source filing: View source filing
Reporting owner signature: /s/ P. Brady Hayden as attorney-in-fact for Jonathan Huberman

Key filing fact

Jonathan Huberman filed Form 4 for CuriosityStream Inc. (CURI) on 06 Feb 2026.

Key facts

This page summarizes Jonathan Huberman's Form 4 filing for CuriosityStream Inc. (CURI).
3 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 06 Feb 2026, 12:19.

Change

Previous filing in this sequence was filed on 24 Nov 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001228716 Primary reporting owner

HUBERMAN JONATHAN

Relationship: Director
Address: 8484 GEORGIA AVE., SUITE 700, SILVER SPRING
Signature: /s/ P. Brady Hayden as attorney-in-fact for Jonathan Huberman
Signature date: 06 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CURI transaction

Common Stock

Options Exercise

Transaction value
Shares: +43,750
Change %: +30%
Price
Shares after: 188,450
Date: 04 Feb 2026
Ownership: Direct
Footnotes: F1

CURI holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,210,169
Date: 04 Feb 2026
Ownership: By 211 LV LLC
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CURI transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -43,750
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 04 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 43,750
Exercise price
Footnotes: F1

CURI transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +21,341
Change %
Price: $0.000000
Shares after: 21,341
Date: 04 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 21,341
Exercise price
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

On February 4, 2026, 43,750 restricted stock units previously granted to Mr. Huberman under the Company's 2020 Omnibus Incentive Plan (the "Plan") vested and converted into shares of the Company's common stock on a one-for-one basis.

Footnote F2

Mr. Huberman holds these securities indirectly as the reporting person and managing member of 211 LV LLC and may be deemed to share beneficial ownership of the securities held directly by 211 LV LLC, and disclaims any beneficial ownership of the reported securities other than to the extent of any pecuniary interest he may have therein, directly or indirectly.

Footnote F3

On Feb 4, 2026 the Company granted Mr. Huberman 21,341 restricted stock units under the Plan. Each restricted stock unit represents a contingent right to receive one share of common stock. The restricted stock units granted will vest on Feb 4, 2027, and will be settled upon vesting (or within 30 days thereafter).